Close Menu

NEW YORK (GenomeWeb) – Seegene today said that the US Food and Drug Administration has cleared for marketing the firm's herpes simplex virus 1 and 2 assay.

The test uses the company's TOCE primer technology (tagging oligonucleotide capture and extension) for multiplexed real-time PCR. It is the first product that Seoul, South Korea-based Seegene has taken through the FDA.

The firm submitted the HSV I & II test to the FDA for use on the Cepheid SmartCycler.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Atlantic reports another SARS-CoV-2 testing problem may be lurking: backlogs.

Researchers have sequenced the genome of "the Methuselah of freshwater fish."

The US Biomedical Advanced Research and Development Authority is supporting efforts to develop vaccines against SARS-CoV-2.

In Genome Biology this week: difference in methylation in neurons from Parkinson's disease patients, differential expression analysis by barcoded sequencing approach, and more.

May
06
Sponsored by
Isoplexis

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.